Management of patent ductus arteriosus in preterm infants

Anadolu Kardiyoloji Dergisi

Volumn 6, Issue 1, 2006, Pages 28-33

  Ekici, Filiz ^a,b   Atasay, Begüm ^a   Günlemez, Ayla ^a   Naçar, Nazire ^a   Tutar, Ercan ^a   Atalay, Semra ^a   Eyileten, Zeynep ^a   Uysalel, Adnan ^a   Arsan, Saadet ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Ductal ligation; Indomethacine; PDA; Preterm infants

Indexed keywords

DOBUTAMINE; DOPAMINE; IBUPROFEN; INDOMETACIN;

ARTICLE; ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; CAUSE OF DEATH; CONSERVATIVE TREATMENT; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FLUID THERAPY; GESTATIONAL AGE; HUMAN; HYPERTENSION; HYPOTENSION; INCIDENCE; INFANT; KIDNEY DYSFUNCTION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MORTALITY; PATENT DUCTUS ARTERIOSUS; PREMATURITY; RECURRENT LARYNGEAL NERVE PALSY; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SEPSIS; SIDE EFFECT; SKIN BLEEDING; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; THROMBOCYTOPENIA; TRACHEAL HEMORRHAGE; TREATMENT CONTRAINDICATION; TREATMENT FAILURE; TREATMENT OUTCOME; URINE VOLUME;

CARDIOVASCULAR AGENTS; DUCTUS ARTERIOSUS, PATENT; ECHOCARDIOGRAPHY, DOPPLER, PULSED; GESTATIONAL AGE; HUMANS; INCIDENCE; INDOMETHACIN; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; LIGATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33645067916     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Park MK, Troxler RG. Manifestation of cardiac problems in newborns. In: Park MK, Troxler RG, editors. Pediatric cardiology for practitioners. 4th ed. St Louis: Mosby; 2002. p. 386-88.
2. Clyman RI. Ibuprofen and patent ductus arteriosus. N Eng J Med 2000; 343: 728-30.
3. Archer N. Drug induced closure of patent ductus arteriosus. Heart 1996; 76: 384-5.
4. Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effects of indomethacine in premature infants with patent ductus arteriosus: Results of a national collaborative study. J Pediatr 1983; 102: 895-906.
5. Artman M, Mahony L, Teitel DF. Approach to the infant with excessive pulmonary blood flow. In: Artman M, Mahony L, Teitel DF, editors. Neonatal Cardiology. New York: McGraw-Hill; 2002. p. 113-5.
6. The CRIB (Clinical Risk index for Babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care unit. The International Neonatal Network. Lancet 1993; 342: 193-8.
7. Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, Degroote K, et al. A comparison of ibuprofen and indomethacine for closure of NEC. N Engl J Med. 2000;343:674-81.
8. Van Overmeire B, Follens I, Hartmann S, Creten WL, Van Acker KJ. Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child Fetal Neonatal Ed 1997; 76: 179-84.
9. Lago P, Bettiol T, Salvadori S, Pitassi I, Vianello A. Safety and efficacy of ibuprofen versus indomethacine in preterm infants treated for patent ductusarteriosus: a randomised controlled trial. Eur J Pediatr 2002; 161:202-7.
10. Tekşam Ö, Yiǧit Ş, Karagöz T, Korkmaz A, Yurdakök M, Tekinalp G. Yenidoǧan bebeklerde patent duktus arteriozusun tedavisinde oral ibuprofen ve intravenbz indometazin: bir retrospektif çalişma. Çocuk Saǧliǧi ve Hastaliklari Dergisi. 2004; 47: 96-102.
11. Akisu ̈M, Özyürek AR, Dorak C, Parlar A, Kültürsay N. Prematüre bebeklerde patent duktus arteriozusun tedavisinde enteral ibuprofen ve indometazin. Çocuk Saǧliǧi ve Hastaliklan Dergisi 2001; 44: 56-60.
12. Satar M, Narh N, Özbarlas N, Atici A, Küçükosmanoǧlu O. Yenidoǧan bebeklerde patent duktus arteriozus ve indometazin tedavisinin deǧerlendirilmesi. Çocuk Saǧliǧi ve Hastaliklari Dergisi 1998; 41: 327-33.
13. Harris JP, Merritt TA, Alexson CG, Longfield L, Manning JA. Parenteral indomethacine for closure of the patent ductus arteriosus. Clinical experience with 67 preterm infants. Am J Dis Child 1982; 136: 1005-8.
14. Zanardo V, Milanesi O, Trevisanuto D, Rizzo M, Ronconi M, Stellin G, et al. Early screening and treatment of "silent" patent ductus arteriosus in prematures with RDS. J Perinat Med 1991; 19: 291-5.
15. Christmann V, Liem KD, Semmekrot BA, van de Bor M. Changes in cerebral, renal and mesenteric blood flow velocity during continuous and bolus infusion of indomethacine. Acta Paediatr 2002; 9: 440-6.
16. Gouyon JB, Chouchane M, Francoise M. Renal effects of prolonged indomethacine therapy in premature infants. Arch Pediatr 1994; 1: 894-7.
17. Dumas de la Roque E, Fayon M, Babre F, Demarquez JL, Pedespan L. Minimal effective dose of indomethacine for the treatment of patent ductus arteriosus in preterm infant Neonate 2002;81:91-4.
18. De Carolis MP, Romagnoli C, Polimeni V, Piersigilli F, Zecca E, Papacci P, et al. Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants. Pediatr 2000; 159: 364-8.
19. Little DC, Pratt TC, Blalock SE, Krauss DR, Cooney DR, Custer MD. Patent ductus arteriosus in micropreemies and full-term infants: The relative merits of surgical ligation versus indomethacine treatment. J Pediatr Surg 2003: 38: 492-6.
20. Mortier E, Ongenae M, Vermassen F, Van Aken J, De Roose J, Van Haesebrouck P, et al. Operative closure of patent ductus arteriosus in the neonatal intensive care unit. Acta Chir Belg 1996; 96: 266-8.
21. Satur CR, Walker DR, Dickinson DF. Day case ligation of patent ductus arteriosus in preterm infants: a 10-year review. Arch Dis Child 1991; 66: 477-80.